Pier Capital LLC Has $8.10 Million Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Pier Capital LLC lifted its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 15.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 382,493 shares of the company's stock after acquiring an additional 52,611 shares during the quarter. Pier Capital LLC owned 0.30% of Surgery Partners worth $8,097,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SGRY. Natixis Advisors LLC lifted its stake in Surgery Partners by 3.0% during the third quarter. Natixis Advisors LLC now owns 12,828 shares of the company's stock worth $414,000 after purchasing an additional 376 shares during the last quarter. Pathstone Holdings LLC lifted its position in shares of Surgery Partners by 30.9% in the 3rd quarter. Pathstone Holdings LLC now owns 57,347 shares of the company's stock worth $1,849,000 after buying an additional 13,534 shares during the last quarter. Intech Investment Management LLC acquired a new position in shares of Surgery Partners in the 3rd quarter valued at about $627,000. Charles Schwab Investment Management Inc. grew its position in shares of Surgery Partners by 5.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 772,746 shares of the company's stock valued at $24,913,000 after buying an additional 38,810 shares during the last quarter. Finally, FMR LLC raised its stake in Surgery Partners by 3.1% during the third quarter. FMR LLC now owns 18,311,867 shares of the company's stock worth $590,375,000 after acquiring an additional 546,869 shares during the period.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY traded down $0.17 during midday trading on Friday, reaching $23.95. 604,842 shares of the company traded hands, compared to its average volume of 1,076,819. The company has a market cap of $3.06 billion, a price-to-earnings ratio of -49.90, a PEG ratio of 19.21 and a beta of 2.73. The stock has a 50-day moving average price of $24.31 and a 200 day moving average price of $25.56. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $33.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Remove Ads

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Sell-side analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Royal Bank of Canada reaffirmed an "outperform" rating and set a $35.00 target price on shares of Surgery Partners in a report on Tuesday. Bank of America initiated coverage on Surgery Partners in a research report on Monday, December 16th. They issued a "buy" rating and a $30.00 target price on the stock. Macquarie reduced their price target on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, Surgery Partners currently has an average rating of "Moderate Buy" and a consensus target price of $36.63.

Insiders Place Their Bets

In other news, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the transaction, the insider now owns 63,408 shares of the company's stock, valued at $1,527,498.72. The trade was a 4.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Harrison R. Bane sold 56,315 shares of the business's stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the completion of the sale, the insider now owns 107,037 shares in the company, valued at $2,744,428.68. The trade was a 34.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 106,622 shares of company stock worth $2,717,860 over the last ninety days. Company insiders own 2.30% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.